SKN | TCGX Acquisition Files for $75 Million IPO Targeting Asian Healthcare Sector
TCGX Acquisition has filed with the U.S. Securities and Exchange Commission (SEC) to raise up to $75 million through an initial public offering as...
SKN | Scribe Therapeutics Targets $100 Million IPO to Advance CRISPR Therapies for Cardiovascular Disease
Scribe Therapeutics, a clinical-stage biotechnology company developing CRISPR-based gene editing therapies for cardiovascular disease, has set the terms for its initial public offering (IPO),...
SKN | Reformation Targets $225 Million IPO at $1.1 Billion Valuation Ahead of NYSE Debut
Reformation Sets IPO Terms
Reformation has officially set the terms for its upcoming initial public offering, seeking to raise $225 million as the sustainable fashion...
SKN | Viking Acquisition Corp. II Advances SPAC IPO Plans as Investors Evaluate New Market Opportunities
Viking Acquisition Corp. II is preparing for its public market debut as the special purpose acquisition company (SPAC) market continues to attract selective investor...
SKN | Goldgroup Mining Inc. Positions for Public Market Growth as Investors Monitor Mining Sector Opportunities
Goldgroup Mining Inc. is attracting attention from investors as the company advances its position within the precious metals sector and evaluates opportunities in the...